Product NDC: | 0007-5180 |
Proprietary Name: | ALTABAX |
Non Proprietary Name: | retapamulin |
Active Ingredient(s): | 10 mg/g & nbsp; retapamulin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0007-5180 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022055 |
Marketing Category: | NDA |
Start Marketing Date: | 20070502 |
Package NDC: | 0007-5180-64 |
Package Description: | 5 g in 1 TUBE (0007-5180-64) |
NDC Code | 0007-5180-64 |
Proprietary Name | ALTABAX |
Package Description | 5 g in 1 TUBE (0007-5180-64) |
Product NDC | 0007-5180 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | retapamulin |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20070502 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | RETAPAMULIN |
Strength Number | 10 |
Strength Unit | mg/g |
Pharmaceutical Classes | pleuromutilin [Chemical/Ingredient],Pleuromutilin Antibacterial [EPC] |